Evidence map›Paper›PMID 30909531›Full record

ArticlePharmaceuticals (Basel, Switzerland)2019

Raman Microspectroscopy as a Tool to Elucidate the Efficacy of Topical Formulations Containing Curcumin.

Ievgeniia Iermak, Ana Paula da Silva, Cristina Kurachi, Vanderlei Salvador Bagnato, Natalia Mayumi Inada

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ievgeniia IermakSão Carlos Institute of Physics, University of São Paulo, Trabalhador Sao-carlense Av., 400, São Carlos, SP 13566-590, Brazil. ievgeniia.iermak@gmail.com.ORCID 0000-0002-9922-3444
Ana Paula da SilvaPDT Pharma Ind. Com. Pharmaceutical Products LTDA, Marechal Deodoro da Fonseca Str., 67, Cravinhos, SP 14140-000, Brazil. ana.paula@pdtpharma.com.br.
Cristina KurachiSão Carlos Institute of Physics, University of São Paulo, Trabalhador Sao-carlense Av., 400, São Carlos, SP 13566-590, Brazil. cristina@ifsc.usp.br.
Vanderlei Salvador BagnatoSão Carlos Institute of Physics, University of São Paulo, Trabalhador Sao-carlense Av., 400, São Carlos, SP 13566-590, Brazil. vander@ifsc.usp.br.
Natalia Mayumi InadaSão Carlos Institute of Physics, University of São Paulo, Trabalhador Sao-carlense Av., 400, São Carlos, SP 13566-590, Brazil. nataliainada@ifsc.usp.br.ORCID 0000-0003-1940-186X
Universidade de São Paulo · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 381132/2010-2Conselho Nacional de Desenvolvimento Científico e Tecnológico 465360/2014-9Fundação de Amparo à Pesquisa do Estado de São Paulo 2013/07276-1
6 · The paper itself

Abstract

The success of the onychomycosis treatment is directly associated with factors such as the choice of the medication, the administration route, and the pharmaceutical formulation. Photodynamic therapy (PDT) is an emerging and promising technique indicated for onychomycosis treatment. For this application, the main challenge is the efficient delivery of the photosensitizer (PS). Curcumin is widely used as a PS, however it is an unstable molecule and it is a challenge to develop a formulation with good penetration into the nail plate, maintaining the stability of curcumin. In this study, the molecular mechanisms underlying the efficacy of two topical formulations containing curcumin used in a clinical trial for onychomycosis treatment were analyzed by Raman microspectroscopy. It is shown that curcumin is present in both formulations in aggregated and non-aggregated states, and in aggregates it is present in different conformations, depending on the interaction with the solvent. This proves to be critical for efficient and uniform PS delivery to the nail and its complete use during the treatment. These analyses are showing how promising Raman microspectroscopy is in understanding the molecular mechanisms of the efficiency of photosensitizers and are helping to improve the development of pharmaceutical formulations.

Indexed as

curcumindrug deliveryonychomycosisphotodynamic therapyphotosensitizerRaman microspectroscopytopical pharmaceutical formulation

Identifiers

PMID30909531
PMCPMC6469165
OpenAlexW2923424493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.